Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CSF Cell-free Tumor DNA (CSF cfDNA) Liquid Biopsies for Pediatric, Adolescent, and Young Adult Patients With Primary Brain Tumors

NCT05934630 is registered in ClinicalTrials.gov with Pediatric Brain Tumor Consortium as lead sponsor.

NCT NCT05934630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05934630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CSF Cell-free Tumor DNA (CSF cfDNA) Liquid Biopsies for Pediatric, Adolescent, and Young Adult Patients With Primary Brain Tumors
Lead sponsor
Pediatric Brain Tumor Consortium
Phase
Observational
Overall status
Terminated
Start date
July 12, 2023
Completion date
April 17, 2026
Enrollment
57 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic astrocytoma, anaplastic oligodendroglioma, atypical teratoid/rhabdoid tumor, choroid plexus carcinoma, cns germ cell tumor, cns primary tumor, nos, diffuse brainstem glioma, diffuse leptomeningeal glioneuronal tumor, ependymoma, nos, fibrillary astrocytoma, glioblastoma multiforme, high-grade astrocytoma nos, low-grade astrocytoma, nos, medulloblastoma, oligodendroglioma, nos, pilocytic astrocytoma, pineoblastoma, supratentorial primitive neuroectodermal tumor